E. Sahai and C. Marshall, RHO???GTPASES AND CANCER, Nature Reviews Cancer, vol.5, issue.2, pp.133-175, 2002.
DOI : 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K

X. Bustelo, Regulatory and Signaling Properties of the Vav Family, Molecular and Cellular Biology, vol.20, issue.5, pp.1461-77, 2000.
DOI : 10.1128/MCB.20.5.1461-1477.2000

S. Katzav, D. Martin-zanca, and M. Barbacid, vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells, EMBO J, vol.8, pp.2283-902477241, 1989.

G. Lazer and S. Katzav, Guanine nucleotide exchange factors for RhoGTPases: Good therapeutic targets for cancer therapy?, Cellular Signalling, vol.23, issue.6, pp.969-79, 2011.
DOI : 10.1016/j.cellsig.2010.10.022

M. Fernandez-zapico, N. Gonzalez-paz, E. Weiss, D. Savoy, J. Molina et al., Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis, Cancer Cell, vol.7, issue.1, pp.39-49, 2005.
DOI : 10.1016/j.ccr.2004.11.024

I. Hornstein, E. Pikarsky, M. Groysman, G. Amir, N. Peylan-ramu et al., The haematopoietic specific signal transducer Vav1 is expressed in a subset of human neuroblastomas, The Journal of Pathology, vol.191, issue.4, pp.526-559, 2003.
DOI : 10.1002/path.1314

R. Bartolomé, I. Molina-ortiz, R. Samaniego, P. Sánchez-mateos, X. Bustelo et al., Activation of Vav/Rho GTPase Signaling by CXCL12 Controls Membrane-Type Matrix Metalloproteinase-Dependent Melanoma Cell Invasion, Cancer Research, vol.66, issue.1, pp.248-58, 2006.
DOI : 10.1158/0008-5472.CAN-05-2489

D. Poppe, I. Tiede, G. Fritz, C. Becker, B. Bartsch et al., Azathioprine Suppresses Ezrin-Radixin-Moesin-Dependent T Cell-APC Conjugation through Inhibition of Vav Guanosine Exchange Activity on Rac Proteins, The Journal of Immunology, vol.176, issue.1, pp.640-5116365460, 2006.
DOI : 10.4049/jimmunol.176.1.640

I. Tiede, G. Fritz, S. Strand, D. Poppe, R. Dvorsky et al., CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes, Journal of Clinical Investigation, vol.111, issue.8, pp.1133-4512697733, 2003.
DOI : 10.1172/JCI16432

V. Tybulewicz, Vav-family proteins in T-cell signalling, Current Opinion in Immunology, vol.17, issue.3, pp.267-74, 2005.
DOI : 10.1016/j.coi.2005.04.003

V. Tybulewicz, L. Ardouin, A. Prisco, L. Reynolds, K. Bi et al., Vav1: a key signal transducer downstream of the TCR Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K-and Vav-dependent pathway, but does not absolutely require phospholipase C, Immunol Rev J Cell Biol, vol.192, issue.157, pp.42-52253, 2002.

M. Villalba, K. Bi, F. Rodriguez, Y. Tanaka, S. Schoenberger et al., Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells, The Journal of Cell Biology, vol.64, issue.3, pp.331-339, 2001.
DOI : 10.1016/S1074-7613(00)80606-8

L. Holsinger, I. Graef, W. Swat, C. T. Bautista, D. Davidson et al., Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction, Current Biology, vol.8, issue.10, pp.563-72, 1998.
DOI : 10.1016/S0960-9822(98)70225-8

K. Fischer, Y. Kong, H. Nishina, K. Tedford, L. Marengère et al., Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor, Current Biology, vol.8, issue.10, pp.554-62, 1998.
DOI : 10.1016/S0960-9822(98)70224-6

S. Ruiz, E. Santos, and X. Bustelo, The Use of Knockout Mice Reveals a Synergistic Role of the Vav1 and Rasgrf2 Gene Deficiencies in Lymphomagenesis and Metastasis, PLoS ONE, vol.4, issue.12, p.8229, 2009.
DOI : 10.1371/journal.pone.0008229.t003

H. Fan, Leukemogenesis by Moloney murine leukemia virus: A multistep process, Trends in Microbiology, vol.5, issue.2, pp.74-82, 1997.
DOI : 10.1016/S0966-842X(96)10076-7

A. West and P. Fraser, Remote control of gene transcription, Human Molecular Genetics, vol.14, issue.suppl_1, pp.101-112, 2005.
DOI : 10.1093/hmg/ddi104

A. Uren, J. Kool, A. Berns, and M. Van-lohuizen, Retroviral insertional mutagenesis: past, present and future, Oncogene, vol.12, issue.52, pp.7656-72, 2005.
DOI : 10.1016/j.ymthe.2003.11.024

J. Garaude, S. Kaminski, S. Charni, J. Aguilò, C. Jacquet et al., Impaired anti-leukemic immune response in PKC??-deficient mice, Molecular Immunology, vol.45, issue.12, pp.3463-3472, 2008.
DOI : 10.1016/j.molimm.2008.03.016

P. Lazo, A. Klein-szanto, and P. Tsichlis, T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications, J Virol, vol.64, pp.3948-592196385, 1990.

S. Clark, E. Chen, M. Fizzotti, O. Witte, and V. Malkovska, BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets, J Virol, vol.67, pp.6033-468396667, 1993.

D. Ott, J. Keller, K. Sill, and A. Rein, Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences, J Virol, vol.66, pp.6107-161326661, 1992.

M. Audit, J. Déjardin, B. Hohl, C. Sidobre, T. Hope et al., Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties, J Virol, vol.73, pp.10472-910559365, 1999.

T. Storch, P. Arnstein, V. Manohar, W. Leiserson, and T. Chused, Proliferation of infected lymphoid precursors before Moloney murine leukemia virus-induced T-cell lymphoma, J Natl Cancer Inst, vol.74, pp.137-433871491, 1985.

A. Sen-majumdar, I. Weissman, G. Hansteen, M. J. Waller, E. Lieberman et al., Radiation leukemia virus-induced thymic lymphomas express a restricted repertoire of T-cell receptor V beta gene products, J Virol, vol.68, pp.1165-728289345, 1994.

J. Raberger, N. Boucheron, S. Sakaguchi, J. Penninger, and W. Ellmeier, Impaired T-cell development in the absence of Vav1 and Itk, European Journal of Immunology, vol.180, issue.12, pp.3530-3572, 2008.
DOI : 10.1002/eji.200838388

G. Doody, S. Bell, E. Vigorito, E. Clayton, S. Mcadam et al., Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation, Nature Immunology, vol.19, issue.6, pp.542-549, 2001.
DOI : 10.1038/88748

K. Tedford, L. Nitschke, I. Girkontaite, A. Charlesworth, G. Chan et al., Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signaling, Nature Immunology, vol.5, issue.6, pp.548-55, 2001.
DOI : 10.1038/88756

M. Tourigny, S. Mazel, D. Burtrum, and H. Petrie, T Cell Receptor (TCR)-?? Gene Recombination: Dissociation from Cell Cycle Regulation and Developmental Progression During T Cell Ontogeny, The Journal of Experimental Medicine, vol.157, issue.9, pp.1549-56, 1997.
DOI : 10.1016/S1074-7613(00)80296-4

E. Hoffman, L. Passoni, T. Crompton, T. Leu, D. Schatz et al., Productive T-cell receptor beta-chain gene rearrangement: coincident regulation of cell cycle and clonality during development in vivo., Genes & Development, vol.10, issue.8, pp.948-62, 1996.
DOI : 10.1101/gad.10.8.948

C. Arnold, J. Wolf, S. Brunner, D. Herndler-brandstetter, and B. Grubeck-loebenstein, Gain and Loss of T Cell Subsets in Old Age???Age-Related Reshaping of the T Cell Repertoire, Journal of Clinical Immunology, vol.460, issue.7251, pp.137-183, 2011.
DOI : 10.1007/s10875-010-9499-x

Y. Gu, J. Siefring, L. Wang, H. Chae, J. Bailey et al., Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation, Oncogene, vol.14, issue.28, pp.3963-72, 2006.
DOI : 10.1038/sj.onc.1209427

S. Charni, G. De-bettignies, M. Rathore, J. Aguiló, P. Van-den-elsen et al., Oxidative Phosphorylation Induces De Novo Expression of the MHC Class I in Tumor Cells through the ERK5 Pathway, The Journal of Immunology, vol.185, issue.6, pp.3498-503, 2010.
DOI : 10.4049/jimmunol.1001250

S. Charni, J. Aguilo, J. Garaude, G. De-bettignies, C. Jacquet et al., ERK5 Knockdown Generates Mouse Leukemia Cells with Low MHC Class I Levels That Activate NK Cells and Block Tumorigenesis, The Journal of Immunology, vol.182, issue.6, pp.3398-405, 2009.
DOI : 10.4049/jimmunol.0803006

URL : https://hal.archives-ouvertes.fr/hal-00368654

K. Takatsuki, K. Yamaguchi, F. Kawano, T. Hattori, H. Nishimura et al., Clinical diversity in adult T-cell leukemia-lymphoma, Cancer Res, vol.45, pp.4644-52861896, 1985.

H. Hasegawa, H. Sawa, M. Lewis, Y. Orba, N. Sheehy et al., Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I, Nature Medicine, vol.43, issue.4, pp.466-72, 2006.
DOI : 10.1016/0076-6879(83)01039-3